Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Consumer Protection Contact Lenses topic
No spam. Unsubscribe anytime.
Utah Senate passes bill to block contact-lens manufacturers’ unilateral pricing policy
Summary
The Senate passed SB169, a consumer-protection bill aimed at preventing contact-lens manufacturers from imposing unilateral pricing policies that, sponsors said, would raise costs for roughly 400,000 Utah wearers by about $22 million a year. Supporters called it a competition-restoring measure; opponents warned of possible legal questions and brand-protection arguments.
Senator Karen Henderson, sponsor of Senate Bill 169, told the Senate the measure was meant to protect Utah consumers from a pricing practice by major contact-lens manufacturers that sets price floors and limits retail competition. "There’s almost 400,000 contact-lens wearers in the state of Utah," Henderson said, and under the new pricing policies "their prices were are set to go up $22,000,000 a year."
Henderson said the bill does not change prescribing authority or clinical oversight: "Nothing in this bill changes that at all. The only thing this bill does is simply ban price fixing," she said. Supporters argued the policy had the practical effect of removing competition by allowing manufacturers to impose a minimum retail price and cut off suppliers who sold below it. "This bill is a bill that protects consumers," Henderson said, adding that market disintermediation has made lenses affordable but that manufacturers were erecting new barriers to competition.
Senator Escamilla, who questioned aspects of the bill, said he had researched whether contact lenses should be treated as a regulated medical device and urged caution about safety and dispensing standards. "I just have a question ... are contact lenses considered medical devices?" he asked, noting other FDA‑regulated devices are subject to separate rules. Henderson responded that contact lenses are prescribed by eye doctors and the bill would not alter clinical prescribing or safety oversight.
Other senators framed the bill as a consumer-versus-brand issue. Senator Stevenson said manufacturers and prescribers who also sell lenses had created a channel for price control and that the state had a role in preventing anti‑competitive practices. Senator Vakas emphasized the consumer choice angle: "Do you want your constituents to be able to go to Costco and buy their contact lenses at a lower price?" he asked.
Opponents raised constitutional and brand‑protection questions. One senator cautioned the measure could be vulnerable to legal challenge as a restriction on a company’s ability to control its distribution or branding, arguing courts have upheld certain brand‑protection measures in other markets.
After extended debate and a short recess to secure attendance for final roll call, Senator Henderson moved the bill as amended. The Senate passed SB169 as amended, the clerk announced, with the roll call recorded as 21 ayes and 8 nays. The bill will be transmitted to the House for consideration.
The Senate record shows proponents framed SB169 primarily as restoring retail competition for contact lenses and preventing manufacturers’ unilateral pricing policies from raising consumer costs; opponents emphasized brand protection and potential constitutional questions. Next steps: the bill is sent to the House for its consideration.
